Genovis AB (publ.) Statistics

Total Valuation

STO:GENO has a market cap or net worth of SEK 1.22 billion. The enterprise value is 1.13 billion.

Market Cap	1.22B
Enterprise Value	1.13B

Important Dates

The next estimated earnings date is Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:GENO has 65.47 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	65.47M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.06%
Owned by Institutions (%)	53.49%
Float	55.61M

Valuation Ratios

The trailing PE ratio is 37.19 and the forward PE ratio is 38.96. STO:GENO's PEG ratio is 0.96.

PE Ratio	37.19
Forward PE	38.96
PS Ratio	8.39
PB Ratio	5.37
P/TBV Ratio	5.57
P/FCF Ratio	33.98
P/OCF Ratio	n/a
PEG Ratio	0.96

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.84, with an EV/FCF ratio of 31.40.

EV / Earnings	34.37
EV / Sales	7.75
EV / EBITDA	20.84
EV / EBIT	25.80
EV / FCF	31.40

Financial Position

The company has a current ratio of 7.38, with a Debt / Equity ratio of 0.34.

Current Ratio	7.38
Quick Ratio	6.01
Debt / Equity	0.34
Debt / EBITDA	1.41
Debt / FCF	2.13
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 15.72% and return on invested capital (ROIC) is 9.52%.

Return on Equity (ROE)	15.72%
Return on Assets (ROA)	8.88%
Return on Invested Capital (ROIC)	9.52%
Return on Capital Employed (ROCE)	14.62%
Revenue Per Employee	4.56M
Profits Per Employee	1.03M
Employee Count	32
Asset Turnover	0.47
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.50% in the last 52 weeks. The beta is 1.69, so STO:GENO's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	-43.50%
50-Day Moving Average	24.74
200-Day Moving Average	25.62
Relative Strength Index (RSI)	25.22
Average Volume (20 Days)	173,103

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:GENO had revenue of SEK 146.00 million and earned 32.92 million in profits. Earnings per share was 0.50.

Revenue	146.00M
Gross Profit	129.90M
Operating Income	43.76M
Pretax Income	46.33M
Net Income	32.92M
EBITDA	54.20M
EBIT	43.76M
Earnings Per Share (EPS)	0.50

Full Income Statement

Balance Sheet

The company has 169.44 million in cash and 76.60 million in debt, giving a net cash position of 92.84 million or 1.42 per share.

Cash & Cash Equivalents	169.44M
Total Debt	76.60M
Net Cash	92.84M
Net Cash Per Share	1.42
Equity (Book Value)	227.97M
Book Value Per Share	3.48
Working Capital	179.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 37.12 million and capital expenditures -1.09 million, giving a free cash flow of 36.03 million.

Operating Cash Flow	37.12M
Capital Expenditures	-1.09M
Free Cash Flow	36.03M
FCF Per Share	0.55

Full Cash Flow Statement

Margins

Gross margin is 88.97%, with operating and profit margins of 29.97% and 22.55%.

Gross Margin	88.97%
Operating Margin	29.97%
Pretax Margin	31.73%
Profit Margin	22.55%
EBITDA Margin	37.13%
EBIT Margin	29.97%
FCF Margin	24.68%

Dividends & Yields

STO:GENO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.69%
FCF Yield	2.94%

Stock Splits

The last stock split was on April 4, 2012. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 4, 2012
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a